Risk stratification with the Haemodynamic Gain Index and peak rate-pressure product in patients with chronic heart failure undergoing treadmill exercise testing
Both HGI and peak RPP are predictors of mortality in patients with chronic HF and may be tools to signal the need for advanced HF therapy evaluation.
Authors
- Yuping Wu (ORCID: https://orcid.org/0000-0002-7892-1876)
- J. Emanuel Finet (ORCID: https://orcid.org/0000-0002-0156-6757)
- Thanat Chaikijurajai (ORCID: https://orcid.org/0000-0003-0651-0434)
- Serge C. Harb (ORCID: https://orcid.org/0000-0002-7442-4928)
- W.H. Wilson Tang (ORCID: https://orcid.org/0000-0002-8335-735X)
- Justin L. Grodin (ORCID: https://orcid.org/0000-0003-2400-3196)
- Wael A. Jaber (ORCID: https://orcid.org/0000-0001-5642-2112)
Institutions
- Cleveland State University (US)
- Cleveland Clinic (US)
- University of Minnesota Rochester (US)
- Mayo Clinic in Arizona (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1093/eurjpc/zwaf046
- Citations
- 5
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.94